P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is 248 805.39 KRW. Compared to the current market price of 198 400 KRW, PharmaResearch Co Ltd is Undervalued by 20%.

Intrinsic Value
248 805.39 KRW
Undervaluation 20%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation Backtest
PharmaResearch Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PharmaResearch Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PharmaResearch Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
PharmaResearch Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about PharmaResearch Co Ltd

Provide an overview of the primary business activities
of PharmaResearch Co Ltd.

What unique competitive advantages
does PharmaResearch Co Ltd hold over its rivals?

What risks and challenges
does PharmaResearch Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for PharmaResearch Co Ltd.

Provide P/S
for PharmaResearch Co Ltd.

Provide P/E
for PharmaResearch Co Ltd.

Provide P/OCF
for PharmaResearch Co Ltd.

Provide P/FCFE
for PharmaResearch Co Ltd.

Provide P/B
for PharmaResearch Co Ltd.

Provide EV/S
for PharmaResearch Co Ltd.

Provide EV/GP
for PharmaResearch Co Ltd.

Provide EV/EBITDA
for PharmaResearch Co Ltd.

Provide EV/EBIT
for PharmaResearch Co Ltd.

Provide EV/OCF
for PharmaResearch Co Ltd.

Provide EV/FCFF
for PharmaResearch Co Ltd.

Provide EV/IC
for PharmaResearch Co Ltd.

Show me price targets
for PharmaResearch Co Ltd made by professional analysts.

What are the Revenue projections
for PharmaResearch Co Ltd?

How accurate were the past Revenue estimates
for PharmaResearch Co Ltd?

What are the Net Income projections
for PharmaResearch Co Ltd?

How accurate were the past Net Income estimates
for PharmaResearch Co Ltd?

What are the EPS projections
for PharmaResearch Co Ltd?

How accurate were the past EPS estimates
for PharmaResearch Co Ltd?

What are the EBIT projections
for PharmaResearch Co Ltd?

How accurate were the past EBIT estimates
for PharmaResearch Co Ltd?

Compare the revenue forecasts
for PharmaResearch Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of PharmaResearch Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of PharmaResearch Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of PharmaResearch Co Ltd compared to its peers.

Compare the P/E ratios
of PharmaResearch Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing PharmaResearch Co Ltd with its peers.

Analyze the financial leverage
of PharmaResearch Co Ltd compared to its main competitors.

Show all profitability ratios
for PharmaResearch Co Ltd.

Provide ROE
for PharmaResearch Co Ltd.

Provide ROA
for PharmaResearch Co Ltd.

Provide ROIC
for PharmaResearch Co Ltd.

Provide ROCE
for PharmaResearch Co Ltd.

Provide Gross Margin
for PharmaResearch Co Ltd.

Provide Operating Margin
for PharmaResearch Co Ltd.

Provide Net Margin
for PharmaResearch Co Ltd.

Provide FCF Margin
for PharmaResearch Co Ltd.

Show all solvency ratios
for PharmaResearch Co Ltd.

Provide D/E Ratio
for PharmaResearch Co Ltd.

Provide D/A Ratio
for PharmaResearch Co Ltd.

Provide Interest Coverage Ratio
for PharmaResearch Co Ltd.

Provide Altman Z-Score Ratio
for PharmaResearch Co Ltd.

Provide Quick Ratio
for PharmaResearch Co Ltd.

Provide Current Ratio
for PharmaResearch Co Ltd.

Provide Cash Ratio
for PharmaResearch Co Ltd.

What is the historical Revenue growth
over the last 5 years for PharmaResearch Co Ltd?

What is the historical Net Income growth
over the last 5 years for PharmaResearch Co Ltd?

What is the current Free Cash Flow
of PharmaResearch Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for PharmaResearch Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PharmaResearch Co Ltd

Current Assets 312.1B
Cash & Short-Term Investments 189.4B
Receivables 53.9B
Other Current Assets 68.9B
Non-Current Assets 289.4B
Long-Term Investments 105.8B
PP&E 138.4B
Intangibles 32.1B
Other Non-Current Assets 13B
Current Liabilities 85.6B
Accounts Payable 10.2B
Accrued Liabilities 1.4B
Short-Term Debt 250m
Other Current Liabilities 73.8B
Non-Current Liabilities 35.1B
Long-Term Debt 1.9B
Other Non-Current Liabilities 33.2B
Efficiency

Earnings Waterfall
PharmaResearch Co Ltd

Revenue
296.6B KRW
Cost of Revenue
-85.6B KRW
Gross Profit
211B KRW
Operating Expenses
-108.8B KRW
Operating Income
102.2B KRW
Other Expenses
-11.4B KRW
Net Income
90.7B KRW

Free Cash Flow Analysis
PharmaResearch Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

PharmaResearch Co Ltd's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Positive Operating Income
71/100
Profitability
Score

PharmaResearch Co Ltd's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

PharmaResearch Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
99/100
Solvency
Score

PharmaResearch Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
PharmaResearch Co Ltd

Wall Street analysts forecast PharmaResearch Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 276 857.14 KRW with a low forecast of 232 300 KRW and a high forecast of 315 000 KRW.

Lowest
Price Target
232 300 KRW
17% Upside
Average
Price Target
276 857.14 KRW
40% Upside
Highest
Price Target
315 000 KRW
59% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PharmaResearch Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PharmaResearch Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

PharmaResearch Co Ltd

Country

Korea

Industry

Biotechnology

Market Cap

2T KRW

Dividend Yield

0.48%

Description

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Contact

GANGWON-DO
Gangneung
77-19, Gwahakdanji-ro
+82336457640
pharmaresearch.co.kr

IPO

2015-07-24

Employees

-

Officers

Chief Executive Officer
Mr. Sang-Soo Jung

See Also

Discover More
What is the Intrinsic Value of one PharmaResearch Co Ltd stock?

The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is 248 805.39 KRW.

Is PharmaResearch Co Ltd stock undervalued or overvalued?

Compared to the current market price of 198 400 KRW, PharmaResearch Co Ltd is Undervalued by 20%.

Back to Top